Journal
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2022.842448
Keywords
cisternal maturation; onco-glycans; GOLPH3; Golgi apparatus; glycosylation
Categories
Funding
- AIRC [IG 15767, IG 20786]
- Italian Cystic Fibrosis Research Foundation [6]
- Italian Node of Euro-Bioimaging (Preparatory Phase II - INFRADEV)
- TERABIO the MIUR PON Project IMPARA
- POR Campania Project 2014-2020 C.I.R.O.
- POR Campania Project 2014-2020 S.A.T.I.N.
Ask authors/readers for more resources
Tumorigenesis is associated with aberrant glycosylation, but the exact cause and mechanisms are still unclear. The levels and localization of glycosylation enzymes determine the glycosylation potential, and the cisternal maturation mechanism plays a key role in Golgi glycan synthesis. This mechanism is proposed to be a combination of pathways that control functionally related glycosylation enzymes. The identification of oncogenes among the cisternal maturation machinery provides insights into the regulation of aberrant glycosylation in cancer cells and potential targets for anticancer treatments.
Tumorigenesis is associated with the deregulation of multiple processes, among which the glycosylation of lipids and proteins is one of the most extensively affected. However, in most cases, it remains unclear whether aberrant glycosylation is a cause, a link in the pathogenetic chain, or a mere consequence of tumorigenesis. In other cases, instead, studies have shown that aberrant glycans can promote oncogenesis. To comprehend how aberrant glycans are generated it is necessary to clarify the underlying mechanisms of glycan synthesis at the Golgi apparatus, which are still poorly understood. Important factors that determine the glycosylation potential of the Golgi apparatus are the levels and intra-Golgi localization of the glycosylation enzymes. These factors are regulated by the process of cisternal maturation which transports the cargoes through the Golgi apparatus while retaining the glycosylation enzymes in the organelle. This mechanism has till now been considered a single, house-keeping and constitutive function. Instead, we here propose that it is a mosaic of pathways, each controlling specific set of functionally related glycosylation enzymes. This changes the conception of cisternal maturation from a constitutive to a highly regulated function. In this new light, we discuss potential new groups oncogenes among the cisternal maturation machinery that can contribute to aberrant glycosylation observed in cancer cells. Further, we also discuss the prospects of novel anticancer treatments targeting the intra-Golgi trafficking process, particularly the cisternal maturation mechanism, to control/inhibit the production of pro-tumorigenic glycans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available